标题
Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer
作者
关键词
-
出版物
Cancers
Volume 11, Issue 5, Pages 690
出版商
MDPI AG
发表日期
2019-05-17
DOI
10.3390/cancers11050690
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update
- (2019) Priyancy G. Jain et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer
- (2019) Sofia Genta et al. Current Oncology Reports
- A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy
- (2019) Peter Hajek et al. NEW ENGLAND JOURNAL OF MEDICINE
- The predictive power of tumor mutational burden in lung cancer immunotherapy response is influenced by patients’ sex
- (2019) Shixiang Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts
- (2019) Paul M. Putora et al. RADIOTHERAPY AND ONCOLOGY
- Mechanisms and therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapy
- (2019) Wei-Di Yu et al. CANCER LETTERS
- Oxidative stress in lung cancer patients is associated with altered serum markers of lipid metabolism
- (2019) Katarzyna Zabłocka-Słowińska et al. PLoS One
- Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer
- (2018) D E Gerber et al. ANNALS OF ONCOLOGY
- Prevalence of Enhancer of Zeste Homolog 2 in Patients with Resected Small Cell Lung Cancer
- (2018) GOUJI TOYOKAWA et al. ANTICANCER RESEARCH
- Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
- (2018) Matthew D. Hellmann et al. CANCER CELL
- Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer
- (2018) Matthew D. Hellmann et al. CANCER CELL
- The FACT inhibitor CBL0137 Synergizes with Cisplatin in Small-Cell Lung Cancer by IncreasingNOTCH1Expression and Targeting Tumor-Initiating Cells
- (2018) Sarmishtha De et al. CANCER RESEARCH
- Combined VEGF and PD-L1 blockade displays synergistic treatment effects in an autochthonous mouse model of small cell lung cancer
- (2018) Lydia Meder et al. CANCER RESEARCH
- Targeting the cancer epigenome: synergistic therapy with bromodomain inhibitors
- (2018) Mahalakshmi Ramadoss et al. DRUG DISCOVERY TODAY
- Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer
- (2018) M. Catherine Pietanza et al. JOURNAL OF CLINICAL ONCOLOGY
- Preparation and anti-cancer evaluation of promiximab-MMAE, an anti-CD56 antibody drug conjugate, in small cell lung cancer cell line xenograft models
- (2018) Lin Yu et al. JOURNAL OF DRUG TARGETING
- Prevalence of Delta-like protein 3 expression in patients with small cell lung cancer
- (2018) Kentaro Tanaka et al. LUNG CANCER
- Higher Lung Cancer Incidence in Young Women Than Young Men in the United States
- (2018) Ahmedin Jemal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antitumor activity of CD56-chimeric antigen receptor T cells in neuroblastoma and SCLC models
- (2018) Denise L. Crossland et al. ONCOGENE
- NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth
- (2018) Khaled Seidi et al. ONCOGENE
- ALK-rearranged adenocarcinoma transformed to small-cell lung cancer: a new entity with specific prognosis and treatment?
- (2018) Charbel Hobeika et al. Personalized Medicine
- EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients
- (2018) Hongyang Lu et al. OncoTargets and Therapy
- The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target
- (2018) David M. Goldenberg et al. Oncotarget
- Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: Results from the exploratory, controlled, randomized, international phase 2 IMPULSE study
- (2018) M Thomas et al. ANNALS OF ONCOLOGY
- Results of the first-in-human study of ABBV-075 (mivebresib), a pan-inhibitor of bromodomain (BD) and extra terminal (BET) proteins, in patients (pts) with relapsed/refractory (R/R) solid tumors.
- (2018) Sarina Anne Piha-Paul et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 2 study of pembrolizumab in advanced small-cell lung cancer (SCLC): KEYNOTE-158.
- (2018) Hyun Cheol Chung et al. JOURNAL OF CLINICAL ONCOLOGY
- Bcl-2 expression in circulating tumor cells (CTCs) of patients with small cell lung cancer (SCLC) receiving front-line treatment
- (2018) Ippokratis Messaritakis et al. LUNG CANCER
- First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
- (2018) Leora Horn et al. NEW ENGLAND JOURNAL OF MEDICINE
- NGR‐hTNF and Doxorubicin as Second‐Line Treatment of Patients with Small Cell Lung Cancer
- (2018) Vanesa Gregorc et al. ONCOLOGIST
- Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma
- (2018) Torsten Kessler et al. Translational Oncology
- Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody–Drug Conjugate
- (2018) Bilal H. Lashari et al. Drugs in research & development
- Crebbp loss drives small cell lung cancer and increases sensitivity to HDAC inhibition
- (2018) Deshui Jia et al. Cancer Discovery
- Tumor mutational burden (TMB) as a biomarker of response to immunotherapy in small cell lung cancer
- (2018) Yanis Boumber Journal of Thoracic Disease
- LBA5Efficacy and safety of nivolumab (nivo) monotherapy versus chemotherapy (chemo) in recurrent small cell lung cancer (SCLC): Results from CheckMate 331
- (2018) M Reck et al. ANNALS OF ONCOLOGY
- A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors
- (2018) Florence Atrafi et al. CLINICAL CANCER RESEARCH
- A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors
- (2018) David C. Smith et al. INVESTIGATIONAL NEW DRUGS
- Randomized Phase II Trial of Cisplatin and Etoposide in Combination With Veliparib or Placebo for Extensive-Stage Small-Cell Lung Cancer: ECOG-ACRIN 2511 Study
- (2018) Taofeek K. Owonikoko et al. JOURNAL OF CLINICAL ONCOLOGY
- EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes
- (2018) Nicolas Marcoux et al. JOURNAL OF CLINICAL ONCOLOGY
- NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018
- (2018) Gregory P. Kalemkerian et al. Journal of the National Comprehensive Cancer Network
- Genetic profiling-based prognostic prediction of patients with advanced small-cell lung cancer in large scale analysis
- (2018) Hibiki Udagawa et al. LUNG CANCER
- COSMIC: the Catalogue Of Somatic Mutations In Cancer
- (2018) John G Tate et al. NUCLEIC ACIDS RESEARCH
- Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin
- (2018) E. Gezelius et al. PLoS One
- Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival
- (2018) Matthew G. Oser et al. Cancer Discovery
- Overcoming T790M mutant small cell lung cancer with the third-generation EGFR-TKI osimertinib
- (2018) Kejing Tang et al. Thoracic Cancer
- Optimal timing of thoracic radiotherapy in limited stage small cell lung cancer (SCLC) with daily fractionation: A brief report
- (2018) Shaakir Hasan et al. RADIOTHERAPY AND ONCOLOGY
- Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032
- (2018) Neal Ready et al. Journal of Thoracic Oncology
- Lenalidomide in the treatment of chronic lymphocytic leukemia
- (2017) Gilad Itchaki et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Molecular alterations of neuroendocrine tumours of the lung
- (2017) Giulio Rossi et al. HISTOPATHOLOGY
- Angiogenesis Inhibitors in NSCLC
- (2017) Anna Manzo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Safety, pharmacokinetic, and pharmacodynamics of erdafitinib, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in patients with advanced or refractory solid tumors
- (2017) Tomohiro Nishina et al. INVESTIGATIONAL NEW DRUGS
- Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial
- (2017) Marcello Tiseo et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)
- (2017) Michael J. Seckl et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapy of Advanced Non–Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab Govitecan
- (2017) Rebecca Suk Heist et al. JOURNAL OF CLINICAL ONCOLOGY
- Small Cell Lung Cancer Exhibits Frequent Inactivating Mutations in the Histone Methyltransferase KMT2D/MLL2 : CALGB 151111 (Alliance)
- (2017) Arnaud Augert et al. Journal of Thoracic Oncology
- OA05.05 Randomized Phase 2 Study: Alisertib (MLN8237) or Placebo + Paclitaxel as Second-Line Therapy for Small-Cell Lung Cancer (SCLC)
- (2017) Taofeek Owonikoko et al. Journal of Thoracic Oncology
- Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer
- (2017) Alberto Ballestrero et al. Journal of Translational Medicine
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study
- (2017) Charles M Rudin et al. LANCET ONCOLOGY
- Outcomes in patients with aggressive or refractory disease from REVEL: A randomized phase III study of docetaxel with ramucirumab or placebo for second-line treatment of stage IV non-small-cell lung cancer
- (2017) Martin Reck et al. LUNG CANCER
- CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancer
- (2017) Lars Henning Schmidt et al. LUNG CANCER
- Vulnerability of Small-Cell Lung Cancer to Apoptosis Induced by the Combination of BET Bromodomain Proteins and BCL2 Inhibitors
- (2017) Lloyd T. Lam et al. MOLECULAR CANCER THERAPEUTICS
- Production of bFGF monoclonal antibody and its inhibition of metastasis in Lewis lung carcinoma
- (2017) Yanqing Yang et al. Molecular Medicine Reports
- Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer
- (2017) Jing Shan Lim et al. NATURE
- Unravelling the biology of SCLC: implications for therapy
- (2017) Joshua K. Sabari et al. Nature Reviews Clinical Oncology
- The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancer
- (2017) A Szczepny et al. ONCOGENE
- Potential therapeutic impact of CD13 expression in non-small cell lung cancer
- (2017) Lars Henning Schmidt et al. PLoS One
- Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy
- (2017) Akane Inoue-Yamauchi et al. Nature Communications
- Significantly mutated genes and regulatory pathways in SCLC—a meta-analysis
- (2017) Varsha Sundaresan et al. Cancer Genetics
- Promiximab-duocarmycin, a new CD56 antibody-drug conjugates, is highly efficacious in small cell lung cancer xenograft models
- (2017) Lin Yu et al. Oncotarget
- Therapeutic strategies and genetic profile comparisons in small cell carcinoma and large cell neuroendocrine carcinoma of the lung using next-generation sequencing
- (2017) Masaoki Ito et al. Oncotarget
- JQ1 synergizes with the Bcl-2 inhibitor ABT-263 against MYCN-amplified small cell lung cancer
- (2017) Huogang Wang et al. Oncotarget
- Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E1508)
- (2016) Chandra P. Belani et al. CANCER
- A randomized, double-blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive-stage small cell lung cancer: Hoosier Cancer Research Network LUN06-113
- (2016) Rachel E. Sanborn et al. CANCER
- A Phase I Clinical Trial and Independent Patient-Derived Xenograft Study of Combined Targeted Treatment with Dacomitinib and Figitumumab in Advanced Solid Tumors
- (2016) Emiliano Calvo et al. CLINICAL CANCER RESEARCH
- A Novel HSP90 Inhibitor-Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer
- (2016) A. V. Gaponova et al. CLINICAL CANCER RESEARCH
- PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer
- (2016) Benjamin H. Lok et al. CLINICAL CANCER RESEARCH
- Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a ‘chemosensitive’ relapse: A single-arm phase II study (EORTC-08061)
- (2016) Fatma Abdelraouf et al. EUROPEAN JOURNAL OF CANCER
- CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
- (2016) Kipp Weiskopf et al. JOURNAL OF CLINICAL INVESTIGATION
- Nivolumab in Combination With Platinum‐Based Doublet Chemotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
- (2016) Naiyer A. Rizvi et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab Monotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
- (2016) Scott Gettinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
- (2016) Scott J Antonia et al. LANCET ONCOLOGY
- Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
- (2016) Corey J Langer et al. LANCET ONCOLOGY
- A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer
- (2016) M. Catherine Pietanza et al. LUNG CANCER
- A phase II study of nintedanib in patients with relapsed small cell lung cancer
- (2016) Ji-Youn Han et al. LUNG CANCER
- Inhibition of PI3K/BMX Cell Survival Pathway Sensitizes to BH3 Mimetics in SCLC
- (2016) Danielle S. Potter et al. MOLECULAR CANCER THERAPEUTICS
- Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo
- (2016) B. A. Helfrich et al. MOLECULAR CANCER THERAPEUTICS
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer
- (2016) Alberto A. Chiappori et al. ONCOLOGIST
- Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer
- (2016) Kaja Skjefstad et al. STEROIDS
- 125I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma
- (2016) Peng-Hui Hu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- MYCL is a target of a BET bromodomain inhibitor, JQ1, on growth suppression efficacy in small cell lung cancer cells
- (2016) Fuyumi Kato et al. Oncotarget
- Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application
- (2016) Young Kwang Chae et al. Oncotarget
- Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction
- (2016) Janine Stucke-Ring et al. Oncotarget
- Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer
- (2016) Nadine S. Jahchan et al. Cell Reports
- Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis
- (2016) Mingming Hu et al. PLoS One
- Cyclophosphamide and tucotuzumab (huKS-IL2) following first-line chemotherapy in responding patients with extensive-disease small-cell lung cancer
- (2015) Oleg Gladkov et al. ANTI-CANCER DRUGS
- Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer
- (2015) Wataru Nakajima et al. CANCER BIOLOGY & THERAPY
- Targeted therapy in cancer
- (2015) Apostolia-Maria Tsimberidou CANCER CHEMOTHERAPY AND PHARMACOLOGY
- PD-L1 expression in small cell neuroendocrine carcinomas
- (2015) Anne M. Schultheis et al. EUROPEAN JOURNAL OF CANCER
- Increased insulin-like growth factor 1 receptor (IGF1R) expression in small cell lung cancer and the effect of inhibition of IGF1R expression by RNAi on growth of human small cell lung cancer NCI-H446 cell
- (2015) Zhigang Wang et al. GROWTH FACTORS
- Organ-specific efficacy of HSP90 inhibitor in multiple-organ metastasis model of chemorefractory small cell lung cancer
- (2015) Shinji Takeuchi et al. INTERNATIONAL JOURNAL OF CANCER
- Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma
- (2015) Yuki Matsumura et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study—CALGB 30504 (Alliance)
- (2015) Neal E. Ready et al. JOURNAL OF CLINICAL ONCOLOGY
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study
- (2015) Bohuslav Melichar et al. LANCET ONCOLOGY
- Tumor Growth Inhibition via Occlusion of Tumor Vasculature Induced by N-Terminally PEGylated Retargeted Tissue Factor tTF-NGR
- (2015) Caroline Brand et al. MOLECULAR PHARMACEUTICS
- Comprehensive genomic profiles of small cell lung cancer
- (2015) Julie George et al. NATURE
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2
- (2015) J T Poirier et al. ONCOGENE
- Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer
- (2015) Hongxin Cao et al. PLoS One
- A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
- (2015) Laura R. Saunders et al. Science Translational Medicine
- Novel and emerging targeted-based cancer therapy agents and methods
- (2015) Mohammad Hojjat-Farsangi TUMOR BIOLOGY
- RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
- (2015) Matthew J. Niederst et al. Nature Communications
- Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors
- (2014) J.- C. Soria et al. ANNALS OF ONCOLOGY
- Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancer
- (2014) G. V. Scagliotti et al. ANNALS OF ONCOLOGY
- Rapamycin Rescues ABT-737 Efficacy in Small Cell Lung Cancer
- (2014) E. E. Gardner et al. CANCER RESEARCH
- CD133+ Cancer Stem-like Cells in Small Cell Lung Cancer Are Highly Tumorigenic and Chemoresistant but Sensitive to a Novel Neuropeptide Antagonist
- (2014) S. Sarvi et al. CANCER RESEARCH
- Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
- (2014) Michelle R. Arkin et al. CHEMISTRY & BIOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Characterization of Fibroblast Growth Factor Receptor 1 in Small-Cell Lung Cancer
- (2014) Anish Thomas et al. Journal of Thoracic Oncology
- A Randomized, Phase 2 Trial of Docetaxel with or without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients with Relapsed or Metastatic Non–Small-Cell Lung Cancer
- (2014) Benjamin Levy et al. Journal of Thoracic Oncology
- Gene mutations in small-cell lung cancer (SCLC): Results of a panel of 6 genes in a cohort of Italian patients
- (2014) Paola Bordi et al. LUNG CANCER
- Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models
- (2014) Kathleen R Whiteman et al. mAbs
- Many players in BCL-2 family affairs
- (2014) Tudor Moldoveanu et al. TRENDS IN BIOCHEMICAL SCIENCES
- A phase Ib dose-escalation study of everolimus combined with cisplatin and etoposide as first-line therapy in patients with extensive-stage small-cell lung cancer
- (2013) B. Besse et al. ANNALS OF ONCOLOGY
- A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours
- (2013) D W Bowles et al. BRITISH JOURNAL OF CANCER
- A phase-1b study of everolimus plus paclitaxel in patients with small-cell lung cancer
- (2013) J M Sun et al. BRITISH JOURNAL OF CANCER
- Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer
- (2013) Reika Iwakawa et al. GENES CHROMOSOMES & CANCER
- Anticancer Therapy by Tumor Vessel Infarction with Polyethylene Glycol Conjugated Retargeted Tissue Factor
- (2013) Christian Schwöppe et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Phase I Study of Pomalidomide (CC-4047) in Combination with Cisplatin and Etoposide in Patients with Extensive-Stage Small-Cell Lung Cancer
- (2013) Peter M. Ellis et al. Journal of Thoracic Oncology
- Fibroblast growth factor receptor 1 (FGFR1) amplification is a potential therapeutic target in small-cell lung cancer
- (2013) Anne M Schultheis et al. MODERN PATHOLOGY
- IGF-1R Targeting Increases the Antitumor Effects of DNA-Damaging Agents in SCLC Model: An Opportunity to Increase the Efficacy of Standard Therapy
- (2013) C. Ferte et al. MOLECULAR CANCER THERAPEUTICS
- Molecular mechanisms underlying RB protein function
- (2013) Frederick A. Dick et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Genomic Deregulation of the E2F/Rb Pathway Leads to Activation of the Oncogene EZH2 in Small Cell Lung Cancer
- (2013) Bradley P. Coe et al. PLoS One
- Mechanisms of Action of Bcl-2 Family Proteins
- (2013) A. Shamas-Din et al. Cold Spring Harbor Perspectives in Biology
- Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
- (2012) C. M. Rudin et al. CLINICAL CANCER RESEARCH
- Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas
- (2012) William D Travis MODERN PATHOLOGY
- Dll4-Fc, an Inhibitor of Dll4-Notch Signaling, Suppresses Liver Metastasis of Small Cell Lung Cancer Cells through the Downregulation of the NF- B Activity
- (2012) T. Kuramoto et al. MOLECULAR CANCER THERAPEUTICS
- MEDI0639: A Novel Therapeutic Antibody Targeting Dll4 Modulates Endothelial Cell Function and Angiogenesis In Vivo
- (2012) D. W. Jenkins et al. MOLECULAR CANCER THERAPEUTICS
- Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
- (2012) Charles M Rudin et al. NATURE GENETICS
- Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment
- (2012) L. Guzman-Rojas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1
- (2012) Lauren Averett Byers et al. Cancer Discovery
- A Functional Role for Tumor Cell Heterogeneity in a Mouse Model of Small Cell Lung Cancer
- (2011) Joaquim Calbo et al. CANCER CELL
- Cell of Origin of Small Cell Lung Cancer: Inactivation of Trp53 and Rb1 in Distinct Cell Types of Adult Mouse Lung
- (2011) Kate D. Sutherland et al. CANCER CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Curaxins: A New Family of Non-genotoxic Multitargeted Anticancer Agents
- (2011) Valeria Di Bussolo et al. ChemMedChem
- Development of bavituximab, a vascular targeting agent with immune-modulating properties, for lung cancer treatment
- (2011) Paul DeRose et al. Immunotherapy
- A crucial requirement for Hedgehog signaling in small cell lung cancer
- (2011) Kwon-Sik Park et al. NATURE MEDICINE
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Aminopeptidase N (CD13) as a target for cancer chemotherapy
- (2010) Malin Wickström et al. CANCER SCIENCE
- Phase II Study of Everolimus (RAD001) in Previously Treated Small Cell Lung Cancer
- (2010) A. Tarhini et al. CLINICAL CANCER RESEARCH
- The PI3K Pathway As Drug Target in Human Cancer
- (2010) Kevin D. Courtney et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment Outcomes by Tumor Histology in Eastern Cooperative Group Study E4599 of Bevacizumab with Paclitaxel/Carboplatin for Advanced Non-small Cell Lung Cancer
- (2010) Alan Sandler et al. Journal of Thoracic Oncology
- Histone H3K27ac separates active from poised enhancers and predicts developmental state
- (2010) M. P. Creyghton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tissue-factor fusion proteins induce occlusion of tumor vessels
- (2010) Christian Schwöppe et al. THROMBOSIS RESEARCH
- Flipping the wound that doesn't heal: the upside of coagulation in cancer
- (2009) B. A. Teicher BLOOD
- Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience
- (2009) R. Bieker et al. BLOOD
- Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
- (2009) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-angiogenic Therapy Using Thalidomide Combined With Chemotherapy in Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2009) Siow Ming Lee et al. JNCI-Journal of the National Cancer Institute
- Expression of Bcl-2 predicts outcome in locally advanced non-small cell lung cancer patients treated with cisplatin-based concurrent chemoradiotherapy
- (2009) Seong Hyun Jeong et al. LUNG CANCER
- Aurora Kinases as Anticancer Drug Targets
- (2008) O. Gautschi et al. CLINICAL CANCER RESEARCH
- Randomized Phase II Study of Carboplatin and Etoposide With or Without thebcl-2Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103
- (2008) Charles M. Rudin et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation